Paul Jorgensen

Paul Jorgensen, with his deep roots in both the scientific and legal domains, stands out as a distinguished figure in the realms of intellectual property and life sciences law. His career is marked by a rich history of engaging with some of the most intricate patent litigations within the pharmaceutical and biotechnology sectors. A former scientist with stints at Harvard Medical School and the University of Toronto, Jorgensen's research once delved into cancer's molecular intricacies, an endeavor that saw him authoring upwards of 20 scientific papers.

Transitioning from the lab to the courtroom, Dr. Jorgensen leverages his scientific acumen to navigate complex patent cases, including trials and appeals before the Federal Court, and issues concerning patent infringement and validity. His expertise isn't confined to patent matters alone; Jorgensen also addresses trademark disputes, product liability cases, and dedicates a portion of his practice to pro bono efforts aimed at housing rights. Additionally, he contributes as an editor to his firm's Pharma in Brief bulletin, ensuring stakeholders are well-informed on the latest developments in pharmaceutical law.

Before his current tenure, Jorgensen honed his legal skills at a top intellectual property boutique firm and through a clerkship at the Court of Appeal for Ontario. His academic journey, which laid the groundwork for his dual expertise, includes a J.D. from Osgoode Hall Law School, a Ph.D. from the University of Toronto, and a B.Sc. from the University of British Columbia.

His contributions to the field have not gone unnoticed, with a recent nod as one of the Best Lawyers in Canada: Ones to Watch in Intellectual Property Law for 2024. Jorgensen is actively involved with several professional organizations, including The Advocates' Society, the Intellectual Property Institute of Canada's Litigation Committee, and the Canadian Bar Association. Beyond the courtroom and committee meetings, he extends his expertise to pro bono work, particularly with the Canadian Centre for Housing Rights and Pro Bono Ontario, underscoring his commitment to leveraging his skills for broader societal benefit.

In recent news, his firm was recognized with two Canadian Impact Cases of the Year Awards by Managing IP in 2021, a testament to the impactful work spearheaded by professionals like Jorgensen. His latest analyses include discussions on Canada's patent term adjustment legislation and a comprehensive guide on global patents, specifically addressing sufficiency of disclosure, further illustrating his pivotal role in shaping intellectual property law's future. Notably, his expertise was central to Pfizer's attempt to challenge a Canadian patent in October 2022, highlighting his ongoing influence in significant legal battles within the pharmaceutical landscape.